181 related articles for article (PubMed ID: 18628254)
1. E2F2 expression induces proliferation of terminally differentiated cardiomyocytes in vivo.
Ebelt H; Zhang Y; Kampke A; Xu J; Schlitt A; Buerke M; Müller-Werdan U; Werdan K; Braun T
Cardiovasc Res; 2008 Nov; 80(2):219-26. PubMed ID: 18628254
[TBL] [Abstract][Full Text] [Related]
2. E2F4 is required for cardiomyocyte proliferation.
van Amerongen MJ; Diehl F; Novoyatleva T; Patra C; Engel FB
Cardiovasc Res; 2010 Apr; 86(1):92-102. PubMed ID: 19955219
[TBL] [Abstract][Full Text] [Related]
3. Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis.
Ebelt H; Hufnagel N; Neuhaus P; Neuhaus H; Gajawada P; Simm A; Müller-Werdan U; Werdan K; Braun T
Circ Res; 2005 Mar; 96(5):509-17. PubMed ID: 15718499
[TBL] [Abstract][Full Text] [Related]
4. E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells.
Garneau H; Paquin MC; Carrier JC; Rivard N
J Cell Physiol; 2009 Nov; 221(2):350-8. PubMed ID: 19562678
[TBL] [Abstract][Full Text] [Related]
5. Directed expression of dominant-negative p73 enables proliferation of cardiomyocytes in mice.
Ebelt H; Zhang Y; Köhler K; Xu J; Gajawada P; Boettger T; Hollemann T; Müller-Werdan U; Werdan K; Braun T
J Mol Cell Cardiol; 2008 Sep; 45(3):411-9. PubMed ID: 18634800
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy.
Busk PK; Hinrichsen R; Bartkova J; Hansen AH; Christoffersen TE; Bartek J; Haunsø S
Exp Cell Res; 2005 Mar; 304(1):149-61. PubMed ID: 15707582
[TBL] [Abstract][Full Text] [Related]
7. PPARgamma ligands suppress the feedback loop between E2F2 and cyclin-E1.
Komatsu Y; Ito I; Wayama M; Fujimura A; Akaogi K; Machida H; Nakajima Y; Kuroda T; Ohmori K; Murayama A; Kimura K; Yanagisawa J
Biochem Biophys Res Commun; 2008 May; 370(1):145-8. PubMed ID: 18355447
[TBL] [Abstract][Full Text] [Related]
8. Cyclin I and p53 are differentially expressed during the terminal differentiation of the postnatal mouse heart.
Liu Y; Tang MK; Cai DQ; Li M; Wong WM; Chow PH; Lee KK
Proteomics; 2007 Jan; 7(1):23-32. PubMed ID: 17154274
[TBL] [Abstract][Full Text] [Related]
9. E2F2 converts reversibly differentiated PC12 cells to an irreversible, neurotrophin-dependent state.
Persengiev SP; Li J; Poulin ML; Kilpatrick DL
Oncogene; 2001 Aug; 20(37):5124-31. PubMed ID: 11526501
[TBL] [Abstract][Full Text] [Related]
10. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy.
Nelson TJ; Balza R; Xiao Q; Misra RP
J Mol Cell Cardiol; 2005 Sep; 39(3):479-89. PubMed ID: 15950986
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1/cdk4 can interact with E2F4/DP1 and disrupts its DNA-binding capacity.
Scimè A; Li L; Ciavarra G; Whyte P
J Cell Physiol; 2008 Mar; 214(3):568-81. PubMed ID: 17894419
[TBL] [Abstract][Full Text] [Related]
12. Suppression of proliferation and cardiomyocyte hypertrophy by CHAMP, a cardiac-specific RNA helicase.
Liu ZP; Olson EN
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2043-8. PubMed ID: 11854500
[TBL] [Abstract][Full Text] [Related]
13. Endothelial nitric oxide synthase promotes neonatal cardiomyocyte proliferation by inhibiting tissue inhibitor of metalloproteinase-3 expression.
Hammoud L; Xiang F; Lu X; Brunner F; Leco K; Feng Q
Cardiovasc Res; 2007 Jul; 75(2):359-68. PubMed ID: 17553475
[TBL] [Abstract][Full Text] [Related]
14. Polypyrimidine tract binding proteins (PTB) regulate the expression of apoptotic genes and susceptibility to caspase-dependent apoptosis in differentiating cardiomyocytes.
Zhang J; Bahi N; Llovera M; Comella JX; Sanchis D
Cell Death Differ; 2009 Nov; 16(11):1460-8. PubMed ID: 19590510
[TBL] [Abstract][Full Text] [Related]
15. Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase.
Tamamori-Adachi M; Takagi H; Hashimoto K; Goto K; Hidaka T; Koshimizu U; Yamada K; Goto I; Maejima Y; Isobe M; Nakayama KI; Inomata N; Kitajima S
Cardiovasc Res; 2008 Nov; 80(2):181-90. PubMed ID: 18596061
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II potentiates DNA synthesis in AT-1 transformed cardiomyocytes.
Fukuda K; Izumo S
J Mol Cell Cardiol; 1998 Oct; 30(10):2069-80. PubMed ID: 9799660
[TBL] [Abstract][Full Text] [Related]
17. The Ets transcription factor GABP is required for cell-cycle progression.
Yang ZF; Mott S; Rosmarin AG
Nat Cell Biol; 2007 Mar; 9(3):339-46. PubMed ID: 17277770
[TBL] [Abstract][Full Text] [Related]
18. Anti-apoptotic function of the E2F transcription factor 4 (E2F4)/p130, a member of retinoblastoma gene family in cardiac myocytes.
Dingar D; Konecny F; Zou J; Sun X; von Harsdorf R
J Mol Cell Cardiol; 2012 Dec; 53(6):820-8. PubMed ID: 22985930
[TBL] [Abstract][Full Text] [Related]
19. TWEAK is a positive regulator of cardiomyocyte proliferation.
Novoyatleva T; Diehl F; van Amerongen MJ; Patra C; Ferrazzi F; Bellazzi R; Engel FB
Cardiovasc Res; 2010 Mar; 85(4):681-90. PubMed ID: 19887380
[TBL] [Abstract][Full Text] [Related]
20. Coordinated regulation of differentiation and proliferation of embryonic cardiomyocytes by a jumonji (Jarid2)-cyclin D1 pathway.
Nakajima K; Inagawa M; Uchida C; Okada K; Tane S; Kojima M; Kubota M; Noda M; Ogawa S; Shirato H; Sato M; Suzuki-Migishima R; Hino T; Satoh Y; Kitagawa M; Takeuchi T
Development; 2011 May; 138(9):1771-82. PubMed ID: 21447557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
